PL, S., P, X., CC, L., C, R., DP, C., & K, H. (2025). Role of Novel Bispecific Antibodies and Immunotherapy in Non-Small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations. JCO precision oncology, 9, e2500023. https://doi.org/10.1200/PO-25-00023
Chicago Style (17th ed.) CitationPL, Su, Xu P, Lin CC, Rolfo C, Carbone DP, and He K. "Role of Novel Bispecific Antibodies and Immunotherapy in Non-Small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations." JCO Precision Oncology 9 (2025): e2500023. https://doi.org/10.1200/PO-25-00023.
MLA (9th ed.) CitationPL, Su, et al. "Role of Novel Bispecific Antibodies and Immunotherapy in Non-Small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations." JCO Precision Oncology, vol. 9, 2025, p. e2500023, https://doi.org/10.1200/PO-25-00023.